Similarly, in an earlier study, the hemagglutinin-neuraminidase (HN) gene of NDV had been demonstrated to function as a powerful molecular adjuvant for DNA anti-tumor vaccination. This evidence concerns the gene MT-RNR2 and neoplasm.